Immunicon Corporation is a diagnostic company developing detection systems based on proprietary technology for the screening, diagnosis and monitoring of cancer in humans.
Immunicon Corporation is a diagnostic company developing detection systems
based on proprietary technology for the screening, diagnosis and monitoring
of cancer in humans.
(NASDAQ: IMMC, acquired by Johnson & Johnson, NYSE: JNJ)